Echo 550 Update: Life-Changing Drug Combinations Discovered
March 13, 2023

Echo 550 Update: Life-Changing Drug Combinations Discovered

Back in 2019, we committed $1 Million to a Drug Discovery Fund with Dr. Li and Lurie Children's Hospital. With these funds, a very sophisticated robot was purchased which can screen drug combinations 382 times faster than a human. The past 3 years seemed like forever, but, we are so excited to announce that WE have progress!

With Dr. Li's work, they have identified a promising panel of drugs that have not been identified before to be active against osteosarcomas, which is bone cancer. They have found HOPE! Remember, there haven't been any new drugs for pediatric cancer in decades. DECADES and the robot that we ALL funded has found promising drugs to hopefully wipe out osteosarcoma.

Additionally, they have generated new data for brain tumors, and are waiting to hear back regarding multi-million dollar funding that would expand their research, all because of the robot. This is a game changer for brain cancer, as well.

Without your support, this would not have been possible. THANK YOU!

November 4, 2016

Cal's Angels funds Lurie Children's groundbreaking children's cancer research

Cal’s Angels partners with Lurie Children’s Hospital and Northwestern University Feinberg School of Medicine to create new treatments for children’s cancers and save more children’s lives.

READ MORE
December 15, 2016

Lurie's Update: December 2016

I would like to express my appreciation for the support and thoughtfulness Cal’s All-Star Angel Foundation has demonstrated in order to provide brighter futures for children and their families. Your investment is enabling us to obtain the necessary personnel and resources to pursue breakthrough research that will produce increasingly more individualized and effective treatments for our patients.

READ MORE
June 1, 2017

Lurie's Update: June 2017

Your support will accelerate our efforts in pediatric drug discovery, making it possible to bring new therapies from the laboratory to human clinical trials in a more efficient and cost-effective way.

READ MORE

Subscribe to our newsletter